Research
Hormonal
Adherence to a Mediterranean diet improves hepatic steatosis and insulin resistance in NAFLD patients, even in the absence of significant weight loss.
Adopt a Mediterranean-style eating pattern focusing on low-glycemic carbohydrates, healthy fats (olive oil, nuts), and high fiber. This approach improves liver fat and insulin sensitivity independently of weight loss, making it a viable strategy even if you struggle to lose weight through caloric restriction alone.
GoodSupportsHIGH confidence
a low glycemic index Mediterranean diet significantly improved hepatic steatosis... as well as markers of insulin resistance... Interestingly, this pattern of diet ameliorates insulin resistance even in the absence of weight loss, acting on a pathophysiological level [41]
Why this rating
Supported by RCTs and large meta-analyses cited in the review.
Source
Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches
Angelo Armandi et al. · Nutrients · 2021
DOI 10.3390/nu13061977
narrative_reviewCited 25×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Weight loss of >10% body weight is required to resolve NASH and regress fibrosis, but this is rarely achieved in routine clinical settings.Strong
- High fructose intake, particularly from sweet beverages, drives hepatic de novo lipogenesis and steatosis in NAFLD, independent of total caloric intake.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →